SCHEMBL25293118

SCHEMBL25293118

CC(C)C(C)NC1CCCc2c1[nH]c1ccccc21

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RB1 P06400 7/20 0.62
CYP2D6 P10635 2/20 0.56
KCNH2 Q12809 1/20 0.56
BRD3 Q15059 2/20 0.55
SIRT1 Q96EB6 2/20 0.49
SIRT2 Q8IXJ6 1/20 0.49
CDC42 P60953 1/20 0.44
GAA P10253 1/20 0.43
CASP6 P55212 1/20 0.43
ADRA1D P25100 1/20 0.43
ADRA1A P35348 1/20 0.43
ADRA1B P35368 1/20 0.43
MEN1 O00255 1/20 0.42
GLA P06280 1/20 0.42
MAPT P10636 1/20 0.42
ALOX15 P16050 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HTR7 P34969 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25248626 1.00 RB1 (0.62) RB1CYP2D6KCNH2BRD3SIRT1
SCHEMBL30455215 0.85 CYP2D6 (0.76) RB1CYP2D6KCNH2BRD3SIRT1
SCHEMBL25287616 0.85 CYP2D6 (0.76) RB1CYP2D6KCNH2BRD3SIRT1
SCHEMBL25247033 0.85 CYP2D6 (0.76) RB1CYP2D6KCNH2BRD3SIRT1
SCHEMBL4196180 0.85 CYP2D6 (0.76) RB1CYP2D6KCNH2BRD3SIRT1
Hydrochloric Acid SCHEMBL4158280 0.84 CYP2D6 (0.74) RB1CYP2D6KCNH2BRD3SIRT1
SCHEMBL30454869 0.83 CYP2D6 (0.72) RB1CYP2D6KCNH2BRD3CDC42
SCHEMBL25293517 0.83 CYP2D6 (0.72) RB1CYP2D6KCNH2BRD3CDC42
SCHEMBL25293518 0.83 CYP2D6 (0.72) RB1CYP2D6KCNH2BRD3CDC42
SCHEMBL25784195 0.83 CYP2D6 (0.72) RB1CYP2D6KCNH2BRD3CDC42

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023121238-A1 SUBSTITUTED HETEROCYCLIC DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME (주)메디픽 2023-06-29 WO disclosed